| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $395.0M | +7.1% |
| Gross Profit | $130.7M | -6.5% |
| R&D Expense | $4.1M | -6.8% |
| SG&A Expense | $114.5M | +2.3% |
| Operating Income | -$24.3M | -89.8% |
| Pre-tax Income | -$47.5M | -100.4% |
| Income Tax | -$9.2M | -318.2% |
| Net Income | -$38.3M | -78.1% |
| EPS (Basic) | -$0.45 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.0M | -17.2% |
| Accounts Receivable | $47.7M | +8.7% |
| Inventory | $30.6M | +41.0% |
| Current Assets | $153.8M | +1.7% |
| Total Assets | $1.12B | +1.9% |
| Current Liabilities | $84.0M | +22.8% |
| Long-term Debt | $401.9M | -1.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23.1M | -44.2% |
| Investing Cash Flow | -$32.8M | -0.9% |
| Financing Cash Flow | -$7.0M | -488.9% |
| -73.1% |
| EPS (Diluted) | -$0.45 | -73.1% |
| Total Liabilities |
| $590.0M |
| +6.1% |
| Stockholders' Equity | $534.9M | -2.4% |